Stimulation with a class A CpG oligonucleotide enhances resistance to infection with feline viruses from five different families
Domestic cats are commonly affected by viral pathogens that induce lengthy infections with fatal outcomes. Prevention of viral propagation is of primordial importance in shelters and catteries, where cats from different backgrounds have narrow contacts. Oligonucleotides (ODN) containing cytosine-pho...
Saved in:
| Published in: | Veterinary research (Paris) Vol. 43; no. 1; pp. 60 - 197 |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
London
BioMed Central
20.08.2012
BioMed Central Ltd BMC |
| Subjects: | |
| ISSN: | 1297-9716, 0928-4249, 1297-9716 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Domestic cats are commonly affected by viral pathogens that induce lengthy infections with fatal outcomes. Prevention of viral propagation is of primordial importance in shelters and catteries, where cats from different backgrounds have narrow contacts. Oligonucleotides (ODN) containing cytosine-phosphate-guanosine motifs of class A (CpG-A) are highly potent synthetic inducers of innate antiviral mechanisms. The aim of this study was to test their ability to modulate innate immune responses and prevent viral replication as stand-alone agents in the domestic cat. CpG-A stimulation of feline peripheral blood mononuclear cells (PBMCs) enhanced their proliferation, increased the presence of co-stimulatory molecules on their surface and influenced their gene expression profiles in an antiviral orientation. Incubation of the supernatants of CpG-A stimulated PBMCs with feline cell lines of epithelial and fibroblastic origin induced expression of the antiviral myxovirus resistance (Mx) gene in these target cells, which also showed enhanced resistance to feline viruses from five distinct families, namely
Coronaviridae
,
Herpesviridae
,
Caliciviridae
,
Parvoviridae
, and
Retroviridae
. Most importantly, subcutaneous administration of CpG-A in domestic cats systemically increased the expression of Mx, reaching maximal levels within 24 h. Plasma from treated cats could furthermore inhibit viral replication
in vitro
. Altogether, our data highlight the promising potential of CpG-A to induce a preventive antiviral state in the cat and to protect feline populations against a broad range of virus infections. |
|---|---|
| AbstractList | Domestic cats are commonly affected by viral pathogens that induce lengthy infections with fatal outcomes. Prevention of viral propagation is of primordial importance in shelters and catteries, where cats from different backgrounds have narrow contacts. Oligonucleotides (ODN) containing cytosine-phosphate-guanosine motifs of class A (CpG-A) are highly potent synthetic inducers of innate antiviral mechanisms. The aim of this study was to test their ability to modulate innate immune responses and prevent viral replication as stand-alone agents in the domestic cat. CpG-A stimulation of feline peripheral blood mononuclear cells (PBMCs) enhanced their proliferation, increased the presence of co-stimulatory molecules on their surface and influenced their gene expression profiles in an antiviral orientation. Incubation of the supernatants of CpG-A stimulated PBMCs with feline cell lines of epithelial and fibroblastic origin induced expression of the antiviral myxovirus resistance (Mx) gene in these target cells, which also showed enhanced resistance to feline viruses from five distinct families, namely Coronaviridae, Herpesviridae, Caliciviridae, Parvoviridae, and Retroviridae. Most importantly, subcutaneous administration of CpG-A in domestic cats systemically increased the expression of Mx, reaching maximal levels within 24 h. Plasma from treated cats could furthermore inhibit viral replication in vitro. Altogether, our data highlight the promising potential of CpG-A to induce a preventive antiviral state in the cat and to protect feline populations against a broad range of virus infections.Domestic cats are commonly affected by viral pathogens that induce lengthy infections with fatal outcomes. Prevention of viral propagation is of primordial importance in shelters and catteries, where cats from different backgrounds have narrow contacts. Oligonucleotides (ODN) containing cytosine-phosphate-guanosine motifs of class A (CpG-A) are highly potent synthetic inducers of innate antiviral mechanisms. The aim of this study was to test their ability to modulate innate immune responses and prevent viral replication as stand-alone agents in the domestic cat. CpG-A stimulation of feline peripheral blood mononuclear cells (PBMCs) enhanced their proliferation, increased the presence of co-stimulatory molecules on their surface and influenced their gene expression profiles in an antiviral orientation. Incubation of the supernatants of CpG-A stimulated PBMCs with feline cell lines of epithelial and fibroblastic origin induced expression of the antiviral myxovirus resistance (Mx) gene in these target cells, which also showed enhanced resistance to feline viruses from five distinct families, namely Coronaviridae, Herpesviridae, Caliciviridae, Parvoviridae, and Retroviridae. Most importantly, subcutaneous administration of CpG-A in domestic cats systemically increased the expression of Mx, reaching maximal levels within 24 h. Plasma from treated cats could furthermore inhibit viral replication in vitro. Altogether, our data highlight the promising potential of CpG-A to induce a preventive antiviral state in the cat and to protect feline populations against a broad range of virus infections. Domestic cats are commonly affected by viral pathogens that induce lengthy infections with fatal outcomes. Prevention of viral propagation is of primordial importance in shelters and catteries, where cats from different backgrounds have narrow contacts. Oligonucleotides (ODN) containing cytosine-phosphate-guanosine motifs of class A (CpG-A) are highly potent synthetic inducers of innate antiviral mechanisms. The aim of this study was to test their ability to modulate innate immune responses and prevent viral replication as stand-alone agents in the domestic cat. CpG-A stimulation of feline peripheral blood mononuclear cells (PBMCs) enhanced their proliferation, increased the presence of co-stimulatory molecules on their surface and influenced their gene expression profiles in an antiviral orientation. Incubation of the supernatants of CpG-A stimulated PBMCs with feline cell lines of epithelial and fibroblastic origin induced expression of the antiviral myxovirus resistance (Mx) gene in these target cells, which also showed enhanced resistance to feline viruses from five distinct families, namely Coronaviridae, Herpesviridae, Caliciviridae, Parvoviridae, and Retroviridae. Most importantly, subcutaneous administration of CpG-A in domestic cats systemically increased the expression of Mx, reaching maximal levels within 24 h. Plasma from treated cats could furthermore inhibit viral replication in vitro. Altogether, our data highlight the promising potential of CpG-A to induce a preventive antiviral state in the cat and to protect feline populations against a broad range of virus infections. Domestic cats are commonly affected by viral pathogens that induce lengthy infections with fatal outcomes. Prevention of viral propagation is of primordial importance in shelters and catteries, where cats from different backgrounds have narrow contacts. Oligonucleotides (ODN) containing cytosine-phosphate-guanosine motifs of class A (CpG-A) are highly potent synthetic inducers of innate antiviral mechanisms. The aim of this study was to test their ability to modulate innate immune responses and prevent viral replication as stand-alone agents in the domestic cat. CpG-A stimulation of feline peripheral blood mononuclear cells (PBMCs) enhanced their proliferation, increased the presence of co-stimulatory molecules on their surface and influenced their gene expression profiles in an antiviral orientation. Incubation of the supernatants of CpG-A stimulated PBMCs with feline cell lines of epithelial and fibroblastic origin induced expression of the antiviral myxovirus resistance (Mx) gene in these target cells, which also showed enhanced resistance to feline viruses from five distinct families, namely Coronaviridae , Herpesviridae , Caliciviridae , Parvoviridae , and Retroviridae . Most importantly, subcutaneous administration of CpG-A in domestic cats systemically increased the expression of Mx, reaching maximal levels within 24 h. Plasma from treated cats could furthermore inhibit viral replication in vitro . Altogether, our data highlight the promising potential of CpG-A to induce a preventive antiviral state in the cat and to protect feline populations against a broad range of virus infections. Abstract Domestic cats are commonly affected by viral pathogens that induce lengthy infections with fatal outcomes. Prevention of viral propagation is of primordial importance in shelters and catteries, where cats from different backgrounds have narrow contacts. Oligonucleotides (ODN) containing cytosine-phosphate-guanosine motifs of class A (CpG-A) are highly potent synthetic inducers of innate antiviral mechanisms. The aim of this study was to test their ability to modulate innate immune responses and prevent viral replication as stand-alone agents in the domestic cat. CpG-A stimulation of feline peripheral blood mononuclear cells (PBMCs) enhanced their proliferation, increased the presence of co-stimulatory molecules on their surface and influenced their gene expression profiles in an antiviral orientation. Incubation of the supernatants of CpG-A stimulated PBMCs with feline cell lines of epithelial and fibroblastic origin induced expression of the antiviral myxovirus resistance (Mx) gene in these target cells, which also showed enhanced resistance to feline viruses from five distinct families, namely Coronaviridae, Herpesviridae, Caliciviridae, Parvoviridae, and Retroviridae. Most importantly, subcutaneous administration of CpG-A in domestic cats systemically increased the expression of Mx, reaching maximal levels within 24 h. Plasma from treated cats could furthermore inhibit viral replication in vitro. Altogether, our data highlight the promising potential of CpG-A to induce a preventive antiviral state in the cat and to protect feline populations against a broad range of virus infections. |
| Audience | Academic |
| Author | Engels, Monika Franchini, Marco Hofmann-Lehmann, Regina Moore, Peter F Rüegger, Vera L Robert-Tissot, Céline Meli, Marina L Riond, Barbara Lutz, Hans Cattori, Valentino |
| AuthorAffiliation | 1 Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, CH-8057, Zurich, Switzerland 2 Department of Pathology, Microbiology and Immunology, 3315 Vet Med 3A, School of Veterinary Medicine, University of California, Davis, CA, 95616, USA 3 Institute of Virology, Vetsuisse Faculty, University of Zürich, Winterthurerstrasse 266a, 8057, Zürich, Switzerland |
| AuthorAffiliation_xml | – name: 3 Institute of Virology, Vetsuisse Faculty, University of Zürich, Winterthurerstrasse 266a, 8057, Zürich, Switzerland – name: 1 Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, CH-8057, Zurich, Switzerland – name: 2 Department of Pathology, Microbiology and Immunology, 3315 Vet Med 3A, School of Veterinary Medicine, University of California, Davis, CA, 95616, USA |
| Author_xml | – sequence: 1 givenname: Céline surname: Robert-Tissot fullname: Robert-Tissot, Céline email: crobert@vetclinics.uzh.ch organization: Clinical Laboratory, Vetsuisse Faculty, University of Zurich – sequence: 2 givenname: Vera L surname: Rüegger fullname: Rüegger, Vera L organization: Clinical Laboratory, Vetsuisse Faculty, University of Zurich – sequence: 3 givenname: Valentino surname: Cattori fullname: Cattori, Valentino organization: Clinical Laboratory, Vetsuisse Faculty, University of Zurich – sequence: 4 givenname: Marina L surname: Meli fullname: Meli, Marina L organization: Clinical Laboratory, Vetsuisse Faculty, University of Zurich – sequence: 5 givenname: Barbara surname: Riond fullname: Riond, Barbara organization: Clinical Laboratory, Vetsuisse Faculty, University of Zurich – sequence: 6 givenname: Peter F surname: Moore fullname: Moore, Peter F organization: Department of Pathology, Microbiology and Immunology, 3315 Vet Med 3A, School of Veterinary Medicine, University of California – sequence: 7 givenname: Monika surname: Engels fullname: Engels, Monika organization: Institute of Virology, Vetsuisse Faculty, University of Zürich – sequence: 8 givenname: Marco surname: Franchini fullname: Franchini, Marco organization: Institute of Virology, Vetsuisse Faculty, University of Zürich – sequence: 9 givenname: Regina surname: Hofmann-Lehmann fullname: Hofmann-Lehmann, Regina organization: Clinical Laboratory, Vetsuisse Faculty, University of Zurich – sequence: 10 givenname: Hans surname: Lutz fullname: Lutz, Hans organization: Clinical Laboratory, Vetsuisse Faculty, University of Zurich |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22906110$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkktv1DAUhSNURB-wZocssWEzrR07drJBqkZQKlViAawtP65nPErswU4GseOn43Ta0kFUKItc3Zzz2Uc5p9VRiAGq6jXB54S0_ILUnVh0gvAFowuOn1UnD5ujR_NxdZrzBmPCacNeVMd13WFOCD6pfn0Z_TD1avQxoB9-XCOFTK9yRpdoub1CsferGCbTQxy9BQRhrYKBjBJkn8d5RmNEPjgwfxgOeh8A7XyactG6FAfk_A6Q9c5BgjAipwbfe8gvq-dO9Rle3b3Pqm8fP3xdflrcfL66Xl7eLAzHeFxorlWjOgeN0FjxhilhXdPYVmuLVccZNhaMbgihBjQQy6iiurMOsGXcCXpWXe-5NqqN3CY_qPRTRuXl7SKmlVRp9CWoVJobTJionXCMCaOFqLnpOm6Z5i2zhfV-z9pOegBrSp6k-gPo4Zfg13IVd5I2VDSsK4B3d4AUv0-QRzn4bKDvVYA4ZUkY43XLa8r-L60Frcut2pn6di9dqZKi_JJYDjezXF42lLG25mwGnv9DVR4LgzelXs6X_YHhzeO0DzHvS1QEzV5gUsw5gZPGj7eNKmTfS4LlXFY511HOdZSMSj77Lv7y3aOfduC9IxdlWEGSmzilUHrzpOU3rw779Q |
| CitedBy_id | crossref_primary_10_3390_v12060640 crossref_primary_10_3390_v13091736 crossref_primary_10_1016_j_vetmic_2014_10_031 crossref_primary_10_1016_j_jcpa_2018_11_001 crossref_primary_10_1016_j_vetimm_2012_07_015 crossref_primary_10_1016_j_ijbiomac_2025_144105 crossref_primary_10_3390_ani11123548 crossref_primary_10_1186_1297_9716_43_82 |
| ContentType | Journal Article |
| Copyright | Robert-Tissot et al.; licensee BioMed Central Ltd. 2012 COPYRIGHT 2012 BioMed Central Ltd. Copyright ©2012 Robert-Tissot et al.; licensee BioMed Central Ltd. 2012 Robert-Tissot et al.; licensee BioMed Central Ltd. |
| Copyright_xml | – notice: Robert-Tissot et al.; licensee BioMed Central Ltd. 2012 – notice: COPYRIGHT 2012 BioMed Central Ltd. – notice: Copyright ©2012 Robert-Tissot et al.; licensee BioMed Central Ltd. 2012 Robert-Tissot et al.; licensee BioMed Central Ltd. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 5PM DOA |
| DOI | 10.1186/1297-9716-43-60 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | MEDLINE - Academic AGRICOLA MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Veterinary Medicine |
| EISSN | 1297-9716 |
| EndPage | 197 |
| ExternalDocumentID | oai_doaj_org_article_ab6c01472f7f447cb7726c996d4b684d PMC3537549 A534482644 22906110 10_1186_1297_9716_43_60 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Switzerland |
| GeographicLocations_xml | – name: Switzerland |
| GroupedDBID | --- 0R~ 123 2VQ 2WC 4.4 53G 5VS AAFWJ AAHBH AAJSJ AASML ACGFS ACGOD ADBBV ADRAZ ADUKV AENEX AFPKN AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AOIJS BAWUL BCNDV BFQNJ BMC C6C CS3 DIK DU5 E3Z EBLON EBS EJD F5P FRP FYUFA GROUPED_DOAJ H13 HYE IAG IAO INH INR IPNFZ ITC KQ8 M41 M48 O5R O5S OK1 PGMZT RBZ RED RIG RNS ROL RPM RSV SMD SOJ --K 1B1 7X7 88E 88I 8FI 8FJ AAOTM AAYXX ABUBZ ABUWG AFFHD AFKRA AZQEC BENPR BPHCQ BVXVI CCPQU CITATION DWQXO EBD ECGQY EMOBN EYRJQ GI~ GNUQQ HCIFZ HMCUK IHE M1P M2P NQ- PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO RPZ SV3 TR2 UKHRP -A0 ACRMQ ADINQ ALIPV C24 CGR CUY CVF ECM EIF M~E NPM 7X8 7S9 L.6 5PM |
| ID | FETCH-LOGICAL-c600t-b6ba5a9fe57b0a654a7df55d8bbd0a9640cdecb5113cebe1d43a3b9dfe0d46f73 |
| IEDL.DBID | RSV |
| ISICitedReferencesCount | 8 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000313159900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1297-9716 0928-4249 |
| IngestDate | Fri Oct 03 12:51:48 EDT 2025 Tue Sep 30 16:44:22 EDT 2025 Wed Oct 01 13:49:38 EDT 2025 Thu Sep 04 15:54:29 EDT 2025 Mon Oct 20 22:50:26 EDT 2025 Mon Oct 20 16:57:58 EDT 2025 Thu Jan 02 22:44:12 EST 2025 Sat Nov 29 06:05:03 EST 2025 Tue Nov 18 21:07:17 EST 2025 Sat Sep 06 07:20:49 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Feline Cell Viral Inhibition Assay Vesicular Stomatitis Virus Proviral Load CrFK Cell |
| Language | English |
| License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c600t-b6ba5a9fe57b0a654a7df55d8bbd0a9640cdecb5113cebe1d43a3b9dfe0d46f73 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://link.springer.com/10.1186/1297-9716-43-60 |
| PMID | 22906110 |
| PQID | 1273268489 |
| PQPubID | 23479 |
| PageCount | 1 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_ab6c01472f7f447cb7726c996d4b684d pubmedcentral_primary_oai_pubmedcentral_nih_gov_3537549 proquest_miscellaneous_1446286234 proquest_miscellaneous_1273268489 gale_infotracmisc_A534482644 gale_infotracacademiconefile_A534482644 pubmed_primary_22906110 crossref_citationtrail_10_1186_1297_9716_43_60 crossref_primary_10_1186_1297_9716_43_60 springer_journals_10_1186_1297_9716_43_60 |
| PublicationCentury | 2000 |
| PublicationDate | 2012-08-20 |
| PublicationDateYYYYMMDD | 2012-08-20 |
| PublicationDate_xml | – month: 08 year: 2012 text: 2012-08-20 day: 20 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Veterinary research (Paris) |
| PublicationTitleAbbrev | Vet Res |
| PublicationTitleAlternate | Vet Res |
| PublicationYear | 2012 |
| Publisher | BioMed Central BioMed Central Ltd BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
| References | 19651532 - Cytokine Growth Factor Rev. 2009 Aug;20(4):283-95 17507184 - Vet Microbiol. 2007 Jul 20;123(1-3):180-6 20384481 - Oligonucleotides. 2010 Apr;20(2):93-101 17548588 - J Immunol. 2007 Jun 15;178(12):7540-9 20003366 - BMC Mol Biol. 2009;10:106 17521745 - Vet Immunol Immunopathol. 2007 Jul 15;118(1-2):68-74 21204950 - Microbiol Immunol. 2011 Mar;55(3):184-90 15879022 - Clin Diagn Lab Immunol. 2005 May;12(5):606-21 15454922 - Nat Immunol. 2004 Oct;5(10):987-95 12184808 - Genome Biol. 2002 Jun 18;3(7):RESEARCH0034 15541797 - Vet Immunol Immunopathol. 2004 Dec 28;102(4):441-50 15070685 - Blood. 2004 Apr 15;103(8):3058-64 10515269 - Vet Microbiol. 1999 Sep 1;69(1-2):51-3 15174975 - Expert Opin Biol Ther. 2004 Jun;4(6):937-46 9764403 - J Vet Med Sci. 1998 Aug;60(8):911-7 8757300 - J Immunol. 1996 Sep 1;157(5):1840-5 16678920 - Antiviral Res. 2006 Oct;72(1):42-8 17067685 - Vet Immunol Immunopathol. 2007 Jan 15;115(1-2):24-34 10623843 - J Immunol. 2000 Jan 15;164(2):944-53 9558060 - J Immunol. 1998 Apr 15;160(8):3627-30 12414749 - Clin Diagn Lab Immunol. 2002 Nov;9(6):1192-9 18575461 - Nat Rev Immunol. 2008 Jul;8(7):559-68 15051512 - Cell Immunol. 2004 Jan;227(1):24-37 7515537 - Vet Microbiol. 1994 Mar;39(1-2):145-52 9725240 - J Immunol. 1998 Sep 1;161(5):2428-34 15123152 - J Feline Med Surg. 2004 Apr;6(2):83-8 1808993 - Adv Exp Med Biol. 1991;310:17-27 21452145 - Schweiz Arch Tierheilkd. 2011 Apr;153(4):157-64 20577268 - Nat Rev Immunol. 2010 Jul;10(7):514-26 16585590 - J Immunol. 2006 Apr 15;176(8):4940-9 15708635 - Antiviral Res. 2005 Feb;65(2):87-95 14977922 - Infect Immun. 2004 Mar;72(3):1223-9 21719112 - Vet Immunol Immunopathol. 2011 Oct 15;143(3-4):269-81 6166723 - J Exp Med. 1981 Jul 1;154(1):199-203 20619456 - Comp Immunol Microbiol Infect Dis. 2010 Dec;33(6):e111-7 11179339 - Infect Immun. 2001 Mar;69(3):1643-9 15771947 - J Feline Med Surg. 2005 Apr;7(2):109-19 17943118 - Nature. 2007 Oct 18;449(7164):819-26 15127838 - Vet Immunol Immunopathol. 2004 Mar;98(1-2):17-29 9862683 - J Immunol. 1998 Dec 15;161(12):6567-74 4308914 - J Virol. 1969 Aug;4(2):147-53 11777536 - Vet Immunol Immunopathol. 2002 Jan 15;84(3-4):223-36 17760705 - Vet Ophthalmol. 2007 Sep-Oct;10(5):278-84 11449369 - Eur J Immunol. 2001 Jul;31(7):2154-63 16740097 - Am J Vet Res. 2006 Jun;67(6):1025-32 12502811 - J Virol. 2003 Jan;77(2):953-62 10430938 - Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9305-10 7700380 - Nature. 1995 Apr 6;374(6522):546-9 12242445 - Science. 2002 Sep 20;297(5589):2063-6 15096181 - Immunology. 2004 May;112(1):28-37 12243889 - Vet Microbiol. 2002 Oct 22;89(2-3):115-27 12572939 - Vet Rec. 2003 Jan 25;152(4):105-8 9645386 - Eur J Immunol. 1998 Jun;28(6):2045-54 17981343 - Vet Immunol Immunopathol. 2008 Feb 15;121(3-4):241-50 17339052 - Mol Immunol. 2007 May;44(12):3234-42 10623847 - J Immunol. 2000 Jan 15;164(2):973-85 17909979 - Vet Res Commun. 2008 Feb;32(2):167-74 11035094 - J Immunol. 2000 Oct 15;165(8):4537-43 14745443 - Nat Med. 2004 Feb;10(2):187-92 15470059 - J Immunol. 2004 Oct 15;173(8):5148-55 9973506 - J Immunol. 1999 Feb 15;162(4):2291-8 8610135 - Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2879-83 12469940 - Int Immunopharmacol. 2002 Nov;2(12):1657-66 15383597 - J Immunol. 2004 Oct 1;173(7):4627-34 11182501 - Vet Microbiol. 2001 Feb 26;78(4):353-62 17683972 - Cytokine Growth Factor Rev. 2007 Oct-Dec;18(5-6):425-33 12778481 - Eur J Immunol. 2003 Jun;33(6):1633-41 11745345 - Eur J Immunol. 2001 Nov;31(11):3281-90 18432822 - Curr Protoc Immunol. 2001 May;Chapter 6:Unit 6.9 15000839 - Oligonucleotides. 2003;13(4):245-59 11763350 - Antisense Nucleic Acid Drug Dev. 2001 Oct;11(5):333-40 10640783 - J Immunol. 2000 Feb 1;164(3):1617-24 11825597 - Vet Immunol Immunopathol. 2002 Jan 1;84(1-2):43-59 19505421 - Vet Res. 2009 Sep-Oct;40(5):45 11970999 - J Immunol. 2002 May 1;168(9):4531-7 10811870 - J Exp Med. 2000 May 15;191(10):1777-88 14971051 - Eur J Immunol. 2004 Jan;34(1):251-62 16698199 - Vet Microbiol. 2006 Oct 5;117(1):14-8 11130078 - Nature. 2000 Dec 7;408(6813):740-5 14511239 - Immunology. 2003 Oct;110(2):250-7 14504106 - Blood. 2004 Feb 1;103(3):1030-2 16054243 - J Virol Methods. 2005 Dec;130(1-2):124-32 9593061 - Antisense Nucleic Acid Drug Dev. 1998 Apr;8(2):181-4 9765447 - J Virol. 1998 Nov;72(11):9025-33 17457344 - Nat Rev Immunol. 2007 May;7(5):379-90 16584295 - Oligonucleotides. 2006 Spring;16(1):58-67 20964643 - Clin Exp Immunol. 2010 Dec;162(3):494-9 20133174 - Vet J. 2011 Mar;187(3):381-7 12773511 - J Leukoc Biol. 2003 Jun;73(6):781-92 |
| References_xml | – reference: 9764403 - J Vet Med Sci. 1998 Aug;60(8):911-7 – reference: 10811870 - J Exp Med. 2000 May 15;191(10):1777-88 – reference: 15879022 - Clin Diagn Lab Immunol. 2005 May;12(5):606-21 – reference: 12502811 - J Virol. 2003 Jan;77(2):953-62 – reference: 17339052 - Mol Immunol. 2007 May;44(12):3234-42 – reference: 21719112 - Vet Immunol Immunopathol. 2011 Oct 15;143(3-4):269-81 – reference: 11130078 - Nature. 2000 Dec 7;408(6813):740-5 – reference: 15123152 - J Feline Med Surg. 2004 Apr;6(2):83-8 – reference: 8757300 - J Immunol. 1996 Sep 1;157(5):1840-5 – reference: 20133174 - Vet J. 2011 Mar;187(3):381-7 – reference: 17909979 - Vet Res Commun. 2008 Feb;32(2):167-74 – reference: 20003366 - BMC Mol Biol. 2009;10:106 – reference: 12242445 - Science. 2002 Sep 20;297(5589):2063-6 – reference: 7700380 - Nature. 1995 Apr 6;374(6522):546-9 – reference: 14511239 - Immunology. 2003 Oct;110(2):250-7 – reference: 17683972 - Cytokine Growth Factor Rev. 2007 Oct-Dec;18(5-6):425-33 – reference: 15708635 - Antiviral Res. 2005 Feb;65(2):87-95 – reference: 6166723 - J Exp Med. 1981 Jul 1;154(1):199-203 – reference: 12469940 - Int Immunopharmacol. 2002 Nov;2(12):1657-66 – reference: 11825597 - Vet Immunol Immunopathol. 2002 Jan 1;84(1-2):43-59 – reference: 15127838 - Vet Immunol Immunopathol. 2004 Mar;98(1-2):17-29 – reference: 16698199 - Vet Microbiol. 2006 Oct 5;117(1):14-8 – reference: 20619456 - Comp Immunol Microbiol Infect Dis. 2010 Dec;33(6):e111-7 – reference: 19505421 - Vet Res. 2009 Sep-Oct;40(5):45 – reference: 20384481 - Oligonucleotides. 2010 Apr;20(2):93-101 – reference: 11970999 - J Immunol. 2002 May 1;168(9):4531-7 – reference: 11777536 - Vet Immunol Immunopathol. 2002 Jan 15;84(3-4):223-36 – reference: 16054243 - J Virol Methods. 2005 Dec;130(1-2):124-32 – reference: 18432822 - Curr Protoc Immunol. 2001 May;Chapter 6:Unit 6.9 – reference: 12773511 - J Leukoc Biol. 2003 Jun;73(6):781-92 – reference: 9593061 - Antisense Nucleic Acid Drug Dev. 1998 Apr;8(2):181-4 – reference: 15454922 - Nat Immunol. 2004 Oct;5(10):987-95 – reference: 9725240 - J Immunol. 1998 Sep 1;161(5):2428-34 – reference: 17067685 - Vet Immunol Immunopathol. 2007 Jan 15;115(1-2):24-34 – reference: 17521745 - Vet Immunol Immunopathol. 2007 Jul 15;118(1-2):68-74 – reference: 12184808 - Genome Biol. 2002 Jun 18;3(7):RESEARCH0034 – reference: 9973506 - J Immunol. 1999 Feb 15;162(4):2291-8 – reference: 17943118 - Nature. 2007 Oct 18;449(7164):819-26 – reference: 12243889 - Vet Microbiol. 2002 Oct 22;89(2-3):115-27 – reference: 9765447 - J Virol. 1998 Nov;72(11):9025-33 – reference: 15000839 - Oligonucleotides. 2003;13(4):245-59 – reference: 10623843 - J Immunol. 2000 Jan 15;164(2):944-53 – reference: 19651532 - Cytokine Growth Factor Rev. 2009 Aug;20(4):283-95 – reference: 15383597 - J Immunol. 2004 Oct 1;173(7):4627-34 – reference: 11763350 - Antisense Nucleic Acid Drug Dev. 2001 Oct;11(5):333-40 – reference: 10515269 - Vet Microbiol. 1999 Sep 1;69(1-2):51-3 – reference: 16584295 - Oligonucleotides. 2006 Spring;16(1):58-67 – reference: 18575461 - Nat Rev Immunol. 2008 Jul;8(7):559-68 – reference: 11035094 - J Immunol. 2000 Oct 15;165(8):4537-43 – reference: 17548588 - J Immunol. 2007 Jun 15;178(12):7540-9 – reference: 11182501 - Vet Microbiol. 2001 Feb 26;78(4):353-62 – reference: 12778481 - Eur J Immunol. 2003 Jun;33(6):1633-41 – reference: 9862683 - J Immunol. 1998 Dec 15;161(12):6567-74 – reference: 21452145 - Schweiz Arch Tierheilkd. 2011 Apr;153(4):157-64 – reference: 12572939 - Vet Rec. 2003 Jan 25;152(4):105-8 – reference: 7515537 - Vet Microbiol. 1994 Mar;39(1-2):145-52 – reference: 14745443 - Nat Med. 2004 Feb;10(2):187-92 – reference: 17760705 - Vet Ophthalmol. 2007 Sep-Oct;10(5):278-84 – reference: 11179339 - Infect Immun. 2001 Mar;69(3):1643-9 – reference: 11745345 - Eur J Immunol. 2001 Nov;31(11):3281-90 – reference: 9558060 - J Immunol. 1998 Apr 15;160(8):3627-30 – reference: 15771947 - J Feline Med Surg. 2005 Apr;7(2):109-19 – reference: 20964643 - Clin Exp Immunol. 2010 Dec;162(3):494-9 – reference: 14977922 - Infect Immun. 2004 Mar;72(3):1223-9 – reference: 17457344 - Nat Rev Immunol. 2007 May;7(5):379-90 – reference: 15051512 - Cell Immunol. 2004 Jan;227(1):24-37 – reference: 15096181 - Immunology. 2004 May;112(1):28-37 – reference: 14971051 - Eur J Immunol. 2004 Jan;34(1):251-62 – reference: 10640783 - J Immunol. 2000 Feb 1;164(3):1617-24 – reference: 16585590 - J Immunol. 2006 Apr 15;176(8):4940-9 – reference: 10430938 - Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9305-10 – reference: 17981343 - Vet Immunol Immunopathol. 2008 Feb 15;121(3-4):241-50 – reference: 21204950 - Microbiol Immunol. 2011 Mar;55(3):184-90 – reference: 12414749 - Clin Diagn Lab Immunol. 2002 Nov;9(6):1192-9 – reference: 15541797 - Vet Immunol Immunopathol. 2004 Dec 28;102(4):441-50 – reference: 14504106 - Blood. 2004 Feb 1;103(3):1030-2 – reference: 20577268 - Nat Rev Immunol. 2010 Jul;10(7):514-26 – reference: 10623847 - J Immunol. 2000 Jan 15;164(2):973-85 – reference: 15070685 - Blood. 2004 Apr 15;103(8):3058-64 – reference: 4308914 - J Virol. 1969 Aug;4(2):147-53 – reference: 17507184 - Vet Microbiol. 2007 Jul 20;123(1-3):180-6 – reference: 15470059 - J Immunol. 2004 Oct 15;173(8):5148-55 – reference: 8610135 - Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2879-83 – reference: 16740097 - Am J Vet Res. 2006 Jun;67(6):1025-32 – reference: 16678920 - Antiviral Res. 2006 Oct;72(1):42-8 – reference: 11449369 - Eur J Immunol. 2001 Jul;31(7):2154-63 – reference: 15174975 - Expert Opin Biol Ther. 2004 Jun;4(6):937-46 – reference: 9645386 - Eur J Immunol. 1998 Jun;28(6):2045-54 – reference: 1808993 - Adv Exp Med Biol. 1991;310:17-27 |
| SSID | ssj0016354 |
| Score | 2.0388618 |
| Snippet | Domestic cats are commonly affected by viral pathogens that induce lengthy infections with fatal outcomes. Prevention of viral propagation is of primordial... Abstract Domestic cats are commonly affected by viral pathogens that induce lengthy infections with fatal outcomes. Prevention of viral propagation is of... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 60 |
| SubjectTerms | Animals B cells Caliciviridae Cat Diseases - immunology Cat Diseases - prevention & control Cat Diseases - virology Cats Cell Line Cell Proliferation Coronaviridae epithelial cells Feline leukemia virus Flow Cytometry - veterinary Gene expression Gene Expression Regulation gene targeting Genetic aspects Health aspects Herpesviridae Immune response immunity Immunity, Innate Immunology Infection Leukocytes, Mononuclear - immunology Male Medicine Medicine & Public Health Microbiology mononuclear leukocytes Myxovirus Resistance Proteins - genetics Myxovirus Resistance Proteins - metabolism Oligodeoxyribonucleotides - administration & dosage Oligodeoxyribonucleotides - pharmacology Oligonucleotides Parvoviridae pathogens Phosphates Physiological aspects Random Allocation Real-Time Polymerase Chain Reaction - veterinary Retroviridae Species Specificity subcutaneous injection Veterinary Medicine/Veterinary Science Virology Virus Diseases - immunology Virus Diseases - prevention & control Virus Diseases - veterinary Virus Diseases - virology Virus Replication viruses Viruses - classification Viruses - immunology |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQxYELgvIVKMhISMAhNLt27OS4VBQOUCEBVW-WP2mkklSbbM_8dGYcZ2mKChduq7U3G3ue7Tf2-A0hLwAWtmBS59oBgrn3NtdBg7MSai65Zy5EAdPjj_LoqDo5qT9fSvWFMWGjPPDYcfvaCAs0Xi6DDJxLa4AOCgss3XEjKu5w9gXWMzlT6fwAltEoHFXj3hF4GEnUZ1GJfVjgZI7CSTlneVSm_L0eRdn-PyfnS6vT1cjJK8encVU6vENuJzpJV2Mz7pIbvt0lu8cY4xIv2tJP6ez8Hvn5ZWh-pGRdFLdfqaYWuTNd0YPz97Q7a753Lcobd0PjPPXtKSKip-CQI8mEz3To6BS9lZ4R8D67pxfNetNDXbytQgPMoHTKvDLQuIcCDvl98u3w3deDD3nKv5BboEFDboTRpa6DL6UptCi5lmC60lXGuELXghfWeWuAsjELWFg4zjQztQu-cFwEyR6QnbZr_SNCy4XmpRPBoPvHAtKKUNUauFowzhU2I28mKyibxMkxR8aZik5KJRSaTaHZFGdKFBl5tf3B-ajLcX3Vt2jWbTUU1I5fAMxUgpn6F8wy8hJBoXDYw4tZnW4vQPNQQEutSgaOLrLLjOzNasJwtbPi5xOsFBZhjFvru00Pry0Zau9U9V_q8HiXeMngOQ9HKG7bFZX7gc1lRM5AOmv4vKRtTqOiOCsxEzL87-sJzipNZf11vfr4f_TqE3ILCOgS9-iXxR7ZGdYb_5TctBdD06-fxSH9C47ET9s priority: 102 providerName: Directory of Open Access Journals |
| Title | Stimulation with a class A CpG oligonucleotide enhances resistance to infection with feline viruses from five different families |
| URI | https://link.springer.com/article/10.1186/1297-9716-43-60 https://www.ncbi.nlm.nih.gov/pubmed/22906110 https://www.proquest.com/docview/1273268489 https://www.proquest.com/docview/1446286234 https://pubmed.ncbi.nlm.nih.gov/PMC3537549 https://doaj.org/article/ab6c01472f7f447cb7726c996d4b684d |
| Volume | 43 |
| WOSCitedRecordID | wos000313159900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: Open Access: BioMedCentral Open Access Titles customDbUrl: eissn: 1297-9716 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0016354 issn: 1297-9716 databaseCode: RBZ dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1297-9716 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0016354 issn: 1297-9716 databaseCode: DOA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1297-9716 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0016354 issn: 1297-9716 databaseCode: RSV dateStart: 20111201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfGQIiXAeVjhVEZCQl4CKS1YyeP3cTgASa0QVXxYvlzizSSqU33zJ_OnZtUZDAkeKmq-JLYzs--O_vuZ0JeACxsyqROtAMEc-9tooMGZyUUXHLPXIgEprOP8ugon8-Lz1tk3OXCxGj3bksyztRxWOfiLSgmmSDhUcJZIsBLvwm6LsexeHwy22wcgP7kLYPPH27qKZ_I0f_7TPyLKroaJnllrzSqoMO7_1H5e2SntTfpdA2Q-2TLVwNy-1O7oz4ggxnGw8SkXNpdfUB-nDTl9_ZgL4pLtVRTi3Y2ndKDi_e0Pi9P6wqpkOumdJ766gzRs6TgvKNBCv9pU9Mu0qt9RsDcd08vy8VqCbKY2UIDzLa0O6WloXG9BZz3h-Tr4bsvBx-S9qyGxILJ1CRGGJ3pIvhMmlSLjGsJnzlzuTEu1YXgqXXeGjDvmAXcjB1nmpnCBZ86LoJkj8h2VVd-l9BsrHnmRDDoKrKAJkjICw12XTDOpXZI3nQfUdmWyBzP0zhX0aHJhcLeVtjbijMl0iF5tbnhYs3hcb3oPqJiI4bk2_FCvThV7VhW2ggLnqWcBBk4l9aAhyIsOI6OG5FzNyQvEVMKpwiomNVtpgM0D8m21DRj4BSjJTokez1JGNq2V_y8Q6XCIoyHq3y9WkK1JUOenrz4iwyPeccTBs95vEbypl2R5R8svyGRPYz3Gt4vqcqzyD7OMjw1Gd77ukO6aqe95XW9-uQfZJ-SO2CTTnDZfpLuke1msfLPyC172ZTLxYjckPN8FBdO4Pd4_9soDv-fp5tWEQ |
| linkProvider | Springer Nature |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqgoALj-W1UMBISMAhJbt27OS4VJQititES9Wb5WcbqSTVbrZnfjoz3mRFCkWCWxRPEtv57JmxZz4T8gpgYVMmdaIdIJh7bxMdNDgroeCSe-ZCJDA9msrZLD8-Lr5skFGXCxOj3bstyThTx2Gdi3egmGSChEcJZ4kAL_0aB3WFUXxfD47WGwegP3nL4POHh3rKJ3L0_z4T_6KKLodJXtorjSpo985_VP4uud3am3SyAsg9suGrAbmx3-6oD8jgCONhYlIu7e7eJz8OmvJ7e7AXxaVaqqlFO5tO6M75R1qflSd1hVTIdVM6T311iuhZUHDe0SCFa9rUtIv0at8RMPfd04tyvlyALGa20ACzLe1OaWloXG8B5_0B-bb74XBnL2nPakgsmExNYoTRmS6Cz6RJtci4lvCbM5cb41JdCJ5a560B845ZwM3IcaaZKVzwqeMiSPaQbFZ15R8Tmo00z5wIBl1FFtAECXmhwa4LxrnUDsl29xOVbYnM8TyNMxUdmlwo7G2Fva04UyIdkjfrB85XHB5Xi75HVKzFkHw73qjnJ6ody0obYcGzlOMgA-fSGvBQhAXH0XEjcu6G5DViSuEUARWzus10gOYh2ZaaZAycYrREh2SrJwlD2_aKX3aoVFiE8XCVr5cLqLZkyNOTF3-R4THveMzgPY9WSF63K7L8g-U3JLKH8V7D-yVVeRrZx1mGpybDd992SFfttLe4qlef_IPsC3Jz73B_qqafZp-fkltgn45xCX-cbpHNZr70z8h1e9GUi_nzOPB_Ap9YVgk |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfQQBMvfJSvwAAjIQEP2bLasZPHMiggRjVpUO3N8ucWaSRVk-6ZP527NKnIYEiItyq-pLHz8_nOvvsdIS8BFjZhUsfaAYK59zbWQYOzEnIuuWcutASm80M5m2UnJ_lRF5tT99Hu_ZHkOqcBWZrKZm_hwnqKZ2IPFikZI_lRzFkswGO_zrFiEDrrx_PNIQKspbxj8_nDTYOFqOXr_10r_7IsXQ6ZvHRu2i5H09v_2ZE75FZnh9LJGjh3yTVfjsj2l-6kfURGc4yTaZN1aX_1Hvlx3BTfu4JfFLdwqaYW7W86oQeLD7Q6L06rEimSq6ZwnvryDFFVU3Dq0VCF37SpaB8B1j0jYE68pxfFclWDLGa80ABamPbVWxra7sOAU3-ffJu-_3rwMe5qOMQWTKkmNsLoVOfBp9IkWqRcS_j8qcuMcYnOBU-s89aA2ccs4GnfcaaZyV3wieMiSPaAbJVV6R8Rmu5rnjoRDLqQLKBpErJcg70XjHOJjchu_0GV7QjOsc7GuWodnUwoHG2Fo604UyKJyOvNDYs1t8fVom8RIRsxJOVuL1TLU9XNcaWNsOBxynGQgXNpDXguwoJD6bgRGXcReYX4Uqg64MWs7jIgoHtIwqUmKQNnGS3UiOwMJGHK20Hzix6hCpswTq701aqG15YM-Xuy_C8yvM1HHjN4zsM1qjf9atn_wSKMiBzgfdDxYUtZnLWs5CzFasrwv2961KtOHdZXjerjf5B9TraP3k3V4afZ5yfkJpitY9zZHyc7ZKtZrvxTcsNeNEW9fNbqgJ-2m17t |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Stimulation+with+a+class+A+CpG+oligonucleotide+enhances+resistance+to+infection+with+feline+viruses+from+five+different+families&rft.jtitle=Veterinary+research+%28Paris%29&rft.au=Robert-Tissot%2C+C%C3%A9line&rft.au=R%C3%BCegger%2C+Vera+L&rft.au=Cattori%2C+Valentino&rft.au=Meli%2C+Marina+L&rft.date=2012-08-20&rft.pub=BioMed+Central&rft.issn=0928-4249&rft.eissn=1297-9716&rft.volume=43&rft.issue=1&rft.spage=60&rft.epage=60&rft_id=info:doi/10.1186%2F1297-9716-43-60&rft_id=info%3Apmid%2F22906110&rft.externalDocID=PMC3537549 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1297-9716&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1297-9716&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1297-9716&client=summon |